These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

61 related articles for article (PubMed ID: 8545550)

  • 21. Determinants of the white-coat effect in hypertensive subjects.
    Mansoor GA; McCabe EJ; White WB
    J Hum Hypertens; 1996 Feb; 10(2):87-92. PubMed ID: 8867561
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The use of ambulatory blood pressure monitoring in managing hypertension according to different treatment guidelines.
    Addison C; Varney S; Coats A
    J Hum Hypertens; 2001 Aug; 15(8):535-8. PubMed ID: 11494091
    [TBL] [Abstract][Full Text] [Related]  

  • 23. White coat effect and white coat hypertension in pediatric patients.
    Matsuoka S; Kawamura K; Honda M; Awazu M
    Pediatr Nephrol; 2002 Nov; 17(11):950-3. PubMed ID: 12432440
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Home blood pressure self-monitoring: diagnostic performance in white-coat hypertension.
    Bayó J; Cos FX; Roca C; Dalfó A; Martín-Baranera MM; Albert B
    Blood Press Monit; 2006 Apr; 11(2):47-52. PubMed ID: 16534404
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A study of the white-coat phenomenon in patients with primary hypertension.
    Zhu N; Bu M; Chen D; Li T; Qian J; Yu Q; Chen Q; Wan C; Qu H; Zhu M; Zou X
    Hypertens Res; 2008 Jan; 31(1):37-41. PubMed ID: 18360016
    [TBL] [Abstract][Full Text] [Related]  

  • 26. White-coat hypertension in adults and children.
    Verdecchia P
    Blood Press Monit; 1999; 4(3-4):175-9. PubMed ID: 10490871
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical evaluation of 24 h ambulatory monitoring of blood pressure under various environmental conditions (home and work versus hospital).
    Paschalis-Purtak K; Pucilowska B; Kabat M; Sznajderman M
    Blood Press Monit; 1998 Oct; 3(5):289-294. PubMed ID: 10212368
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prevalence of the white-coat effect at multiple visits before and during treatment.
    Verberk WJ; Kroon AA; Thien T; Lenders JW; van Montfrans GA; Smit AJ; de Leeuw PW
    J Hypertens; 2006 Dec; 24(12):2357-63. PubMed ID: 17082716
    [TBL] [Abstract][Full Text] [Related]  

  • 29. White coat hypertension in adolescents.
    Koch VH; Furusawa EA; Saito MI; Colli A; Ignes EC; Okay Y; Mion Júnior D
    Clin Nephrol; 1999 Nov; 52(5):297-303. PubMed ID: 10584993
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Factors influencing white-coat effect.
    Manios ED; Koroboki EA; Tsivgoulis GK; Spengos KM; Spiliopoulou IK; Brodie FG; Vemmos KN; Zakopoulos NA
    Am J Hypertens; 2008 Feb; 21(2):153-8. PubMed ID: 18174883
    [TBL] [Abstract][Full Text] [Related]  

  • 31. White-coat hypertension: not guilty when correctly defined.
    Verdecchia P; Schillaci G; Borgioni C; Ciucci A; Porcellati C
    Blood Press Monit; 1998 Jun; 3(3):147-152. PubMed ID: 10212345
    [TBL] [Abstract][Full Text] [Related]  

  • 32. White coat hypertension in centenarians.
    Jumabay M; Ozawa Y; Kawamura H; Saito S; Izumi Y; Mitsubayashi H; Kasamaki Y; Nakayama T; Cheng Z; Ma Y; Mahumut M
    Am J Hypertens; 2005 Aug; 18(8):1040-5. PubMed ID: 16109317
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Detecting white coat and reverse white coat effects in clinic settings using measures of blood pressure habituation in the clinic and patient self-monitoring of blood pressure.
    Larkin KT; Schauss SL; Elnicki DM; Goodie JL
    J Hum Hypertens; 2007 Jul; 21(7):516-24. PubMed ID: 17361194
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Reverse white-coat effect as an independent risk for microalbuminuria in treated hypertensive patients.
    Kato T; Horio T; Tomiyama M; Kamide K; Nakamura S; Yoshihara F; Nakata H; Nakahama H; Kawano Y
    Nephrol Dial Transplant; 2007 Mar; 22(3):911-6. PubMed ID: 17142262
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Myths and reality concerning hypertension in peritoneal dialysis patients: results of a multicenter study.
    Lucatello A; Cocchi R; Degli Esposti E ; Fabbri A; Sturani A; Quarello F; Boero R; Dadone C; Bruno M; Favazza A; Scanziani R; Tommasi A; Giangrande A
    Blood Press Monit; 1998 Apr; 3(2):83-90. PubMed ID: 10212335
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The white coat phenomenon is benign in referred treated patients: a 14-year ambulatory blood pressure mortality study.
    Ben-Dov IZ; Kark JD; Mekler J; Shaked E; Bursztyn M
    J Hypertens; 2008 Apr; 26(4):699-705. PubMed ID: 18327079
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Early detection by non-invasive monitoring of abnormally elevated systolic blood pressure in newborns with a positive familiarity for hypertension.
    Menghetti E; Mucedola G; Marulli P; Montaleone M; Cugini P
    Recenti Prog Med; 1995 May; 86(5):195-7. PubMed ID: 7604175
    [TBL] [Abstract][Full Text] [Related]  

  • 38. ["White coat hypertension" syndrome in resistant essential hypertension].
    Kawecka-Jaszcz K; Rajzer M; Królikowski T; Zietara E
    Przegl Lek; 1992; 49(11):369-71. PubMed ID: 1306569
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Epidemiology of hypertension in the elderly.
    Fagard RH
    Am J Geriatr Cardiol; 2002; 11(1):23-8. PubMed ID: 11773712
    [TBL] [Abstract][Full Text] [Related]  

  • 40. High prevalence of white-coat hypertension in Spanish resistant hypertensive patients.
    Elliott WJ
    Hypertension; 2011 May; 57(5):889-90. PubMed ID: 21444834
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.